Skip to main content

VERTIS CV: Ertugliflozin’s proven benefits fall short of other SGLT2 inhibitors

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
VERTIS CV: Ertugliflozin’s proven benefits fall short of other SGLT2 inhibitors

User login

Username

Password

Reset your password

Type	Lead	score